Exact Sciences Cor (NASDAQ:EXAS).
Baird Financial Group, Inc. reports that it sold 912 shares during the last quarter decreasing its stake in Exact Sciences Cor (EXAS) by 0.4%. Its investment was valued at $11,257,000 an increase of 32.7% as of the end of the quarter.
These firms have modified their investment in EXAS. As of quarter end Oppenheimerfunds, Inc. had bought a total of 20,938 shares growing its stake by 0.7%. The value of the investment in Exact Sciences Cor increased from $106,610,000 to $143,013,000 a change of $36,403,000 since the last quarter. First Mercantile Trust Co cut its stake by selling 1,221 shares a decrease of 39.5% in the quarter. First Mercantile Trust Co currently owns 1,869 shares valued at $88,000. The total value of its holdings decreased 19.3%.
Baird Financial Group, Inc. reduced its ownership by shedding 912 shares a decrease of 0.4% from 06/30/2017 to 09/30/2017. Baird Financial Group, Inc. controls 238,902 shares worth $11,257,000. The value of the position overall is up by 32.7%. As of the end of the quarter Baird Financial Group, Inc. had disposed of 912 shares trimming its position 0.4%. The value of the investment in EXAS went from $8,482,000 to $11,257,000 increasing 32.7% for the reporting period.
Raymond James & Associates grew its investment by buying 5,537 shares an increase of 6.0% as of 09/30/2017. Raymond James & Associates now controls 97,609 shares with a value of $4,599,000. The total value of its holdings increased 41.2%.
Equity analyst Robert W. Baird raised the price target on October 31 changing the price objective from $49.00 to $56.00 and issued a “Outperform” rating.
On October 31 Benchmark maintained a stock rating of “Buy” with a current price target of $60.00. Jefferies Group LLC raised the price target of the stock on October 31 boosting the projection from $0.00 to $60.00 and issued a “Buy” recommendation.
October 31 investment analysts at Leerink Swann held the stock rating at “Outperform” targeting a price of $63.00.
The company is so far trading down from yesterday’s close of 58.33. Exact Sciences Cor’s P/E ratio is N/A and the market value is 6.98B. In the latest earnings report the EPS was $-1.15 with 119.73M shares presently outstanding.
Investors are feeling more bullish on shares of the company recently looking at the downtick in short interest. The company experienced a fall in short interest of -2.54% as of October 13, 2017 from the last reporting period. Short interest decreased from 10,994,802 to 10,716,019 over that period. With short interest at 10,716,019 and short average daily volume at 1,522,157, the short-interest ratio is 7.0 and the short interest percentage is 0.09% as of October 13.